Share：
Share this content in WeChat
X
[Chinese][PDF]127695
• Review •
Advances in magnetic resonance imaging in the diagnosis of prostate cancer
SUN Bixia  ZHANG Hao  ZHANG Xuxia  LUO Yinli  YUE Mengying  LU Zhongyan 

Cite this article as: Sun BX, Zhang H, Zhang XX, et al. Advances in magnetic resonance imaging in the diagnosis of prostate cancer. Chin J Magn Reson Imaging, 2019, 10(12): 947-950. DOI:10.12015/issn.1674-8034.2019.12.017.


[Abstract] Because magnetic resonance imaging (MRI) has the advantages of good soft tissue resolution, multi-directional imaging and multi-parameter functional imaging, it has gradually become an important imaging method for the diagnosis of prostate cancer. With the maturity of MRI imaging technology, a variety of imaging methods such as magnetic resonance perfusion imaging (PWI), diffusion-weighted imaging (DWI), intravoxel irrelevant motion (IVIM) diffusion imaging, magnetic resonance spectroscopy (MRS), diffusion tensor imaging (DTI), diffusion kurtosis imaging (DKI), T2 mapping and magnetic susceptibility weighted imaging (SWI) play an important role in the diagnosis of prostate cancer. With the development of these technologies, the accuracy of prostate cancer diagnosis has been significantly improved. The role of magnetic resonance imaging in the diagnosis of prostate cancer in recent years is reviewed.
[Keywords] prostatic neoplasms；magnetic resonance imaging；diffusion weighted imaging；magnetic resonance spectroscopy；diffusion tensor imaging；diffusion kurtosis imaging

SUN Bixia The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; Department of Radiology, the First Hospital of Lanzhou University, Lanzhou 730000, China

ZHANG Hao * Department of Radiology, the First Hospital of Lanzhou University, Lanzhou 730000, China

ZHANG Xuxia The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; Department of Radiology, the First Hospital of Lanzhou University, Lanzhou 730000, China

LUO Yinli The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; Department of Radiology, the First Hospital of Lanzhou University, Lanzhou 730000, China

YUE Mengying The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; Department of Radiology, the First Hospital of Lanzhou University, Lanzhou 730000, China

LU Zhongyan The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; Department of Radiology, the First Hospital of Lanzhou University, Lanzhou 730000, China

*Corresponding to: Zhang H, E-mail: zhanghao@lzu.edu.cn

Conflicts of interest   None.

Received  2019-04-02
DOI: 10.12015/issn.1674-8034.2019.12.017
Cite this article as: Sun BX, Zhang H, Zhang XX, et al. Advances in magnetic resonance imaging in the diagnosis of prostate cancer. Chin J Magn Reson Imaging, 2019, 10(12): 947-950. DOI:10.12015/issn.1674-8034.2019.12.017.

[1]
Miller KD, Sauer AG, Ortiz AP, et al. Cancer statistics for hispanics/latinos. Ca-Cancer J Clin, 2018, 68(6): 425-445.
[2]
Liu Y, Wang W, Gao G, et al. The applied research of simultaneous image acquisition of T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) in the assessment of patients with prostate cancer. Asian J Androl, 2019, 21(2): 177-182.
[3]
赵斌．磁共振灌注成像临床应用及进展．磁共振成像, 2014, 5(S1): 46-50.
[4]
方俊华,闵祥德，冯朝燕，等．磁共振灌注加权成像定量参数在前列腺外周带前列腺癌鉴别诊断中的价值．磁共振成像, 2015, 6(2): 136-140.
[5]
Ma XZ, Lv K, Sheng JL, et al. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer. Oncol Lett, 2019, 17(3): 3077-3084.
[6]
Mussi TC, Martins T, Tachibana A, et al. Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI. Inter Braz J Urol, 2018, 44(5): 882-891.
[7]
李远章，梁健华，赵业城，等．多b值磁共振扩散加权成像结合动态增强扫描成像对前列腺癌的早期诊断研究．中国基层医药, 2018, 25(12): 1536-1539.
[8]
Frangioni JV. New technologies for human cancer imaging. J Clin Oncol, 2008, 26(24): 4012-4021.
[9]
Li B, Cai WC, Lv DJ, et al. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis. J Magn Reson Imaging, 2013, 37(1): 194-200.
[10]
Kumar V, Jagannathan NR, Kumar R, et al. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging, 2006, 24(5): 541-548.
[11]
Zhang TH, Hu CH, Chen JX, et al. Differentiation diagnosis of hypo-intense T2 area in unilateral peripheral zone of prostate using magnetic resonance spectroscopy (MRS): Prostate carcinoma versus prostatitis. Med Sci Monitor, 2017, 23: 3837-3843.
[12]
Tian W, Zhang J, Tian F, et al. Correlation of diffusion tensor imaging parameters and Gleason scores of prostate cancer. Exp Ther Med, 2018, 15(1): 351-356.
[13]
Gurses B, Tasdelen N, Yencilek F, et al. Diagnostic utility of DTI in prostate cancer. Eur J Radiol, 2011, 79(2): 172-176.
[14]
Gholizadeh N, Greer PB, Simpson J, et al. Characterization of prostate cancer using diffusion tensor imaging: A new perspective. Eur J Radiol, 2019, 110: 112-120.
[15]
Di Trani MG, Nezzo M, Caporale AS, et al. Performance of diffusion kurtosis imaging versus diffusion tensor imaging in discriminating between benign tissue, low and high gleason grade prostate cancer. Acad Radiol, 2018, 32(18): 30530.
[16]
Tamura C, Shinmoto H, Soga S, et al. Diffusion kurtosis imaging study of prostate cancer: preliminary findings. J Magn Reson Imaging, 2014, 40(3): 723-729.
[17]
Wang X, Tu N, Qin T, et al. Diffusion kurtosis imaging combined with DWI at 3-T MRI for detection and assessment of aggressiveness of prostate cancer. AJR Am J Roentgenol, 2018, 211(4): 797-804.
[18]
Mai J, Abubrig M, Lehmann T, et al. T2 mapping in prostate cancer. Invest Radiol, 2018, 54(3): 146-152.
[19]
Wu LM, Chen XX, Xuan HQ, et al. Feasibility and preliminary experience of quantitative T2(star) mapping at 3.0 T for detection and assessment of aggressiveness of prostate cancer. Acad Radiol, 2014, 21(8): 1020-1026.
[20]
Wu LM, Yao QY, Zhu J, et al. T2* mapping combined with conventional T2-weighted image for prostate cancer detection at 3.0 T MRI: a multi-observer study. Acta Radiol, 2017, 58(1): 114-120.
[21]
Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging, 2005, 22(4): 439-450.
[22]
Liu SF, Buch S, Chen YS, et al. Susceptibility-weighted imaging: current status and future directions. NMR Biomed, 2017 Apr;30(4). DOI: 10.1002/nbm.3552.
[23]
Bai Y, Wang MY, Han YH, et al. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification. PLoS One, 2013, 8(1): e53237.

PREV Research progress on magnetic resonance imaging of cervical spondylosis myelopathy
NEXT Application and research progress of MRI texture analysis in the diagnosis and treatment of prostate cancer
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn